The bionic pancreas system could be the key to accurately control levels of sugar in the blood. Experts say, it's demonstrating better in clinical trials at controlling glucose levels in patients with type 1 diabetes without danger of hypoglycemia (low glucose) than customary or sensor-enlarged insulin pump treatment.
Specialists at Boston University conducted a study in type 1 diabetes patients over a 11-day time span at their homes without any confinements.
The bionic pancreas, which controls patients' glucose with both insulin and glucagon, a hormone that expands glucose levels, was produced by Edward Damiano, Ph.D., and Firas El-Khatib, Ph.D., of the BU Department of Biomedical Engineering.
The system comprises of a cell phone that can remotely speak with two pumps conveying insulin and glucagon. The cell phone got glucose readings from the consistent glucose screen like clockwork, which it used to figure and manage a dosage of the insulin or glucagon.
There have been three past trials of the bionic pancreas, a 2010 clinical trial demonstrating that the first gadget kept up close typical glucose levels for over 24 hours in grown-up patients with type 1 diabetes, and a 2014 New England Journal of Medicine paper, which demonstrated that a redesigned adaptation of the system effectively controlled glucose levels in grownups and young people for five days.
The third past trial published in The Lancet Diabetes and Endocrinology in 2016 demonstrated the bionic pancreas could effectively control blood sugars in youngsters as youthful as 6.
In the recent trial, members had the choice to enter carb tallies into the smartphone for every dinner to permit the system to convey insulin measurements, yet it wasn't required.
The present trial demonstrated that while wearing the bionic pancreas, members' normal blood glucose levels were essentially lower - 141 mg/dl versus 162 mg/dl - than when on standard treatment. Hypoglycemia levels (under 60mg/dl) for 0.6 percent of the time while wearing the bionic pancreas contrasted with 1.9 percent with standard treatment.
Another good news for health today! Because of these bionic pancreas we might be able to eat our favorite cakes! But of course, still in moderation.